X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6377) 6377
Newsletter (711) 711
Publication (454) 454
Book Review (107) 107
Newspaper Article (41) 41
Magazine Article (31) 31
Book Chapter (16) 16
Dissertation (7) 7
Trade Publication Article (6) 6
Conference Proceeding (3) 3
Government Document (1) 1
Journal / eJournal (1) 1
Presentation (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
paroxetine (4968) 4968
humans (4101) 4101
male (3076) 3076
female (2760) 2760
psychiatry (2701) 2701
adult (2166) 2166
pharmacology & pharmacy (1770) 1770
middle aged (1724) 1724
index medicus (1702) 1702
paroxetine - therapeutic use (1530) 1530
serotonin uptake inhibitors - therapeutic use (1381) 1381
antidepressants (1368) 1368
fluoxetine (1282) 1282
neurosciences (1278) 1278
depression (1254) 1254
treatment outcome (1236) 1236
double-blind (1008) 1008
aged (976) 976
animals (925) 925
serotonin (903) 903
clinical neurology (868) 868
double-blind method (785) 785
serotonin uptake inhibitors - adverse effects (771) 771
paroxetine - adverse effects (766) 766
depressive disorder - drug therapy (749) 749
sertraline (737) 737
major depression (732) 732
antidepressive agents - therapeutic use (727) 727
depression, mental (710) 710
research (702) 702
paroxetine - pharmacology (663) 663
depressive disorder, major - drug therapy (657) 657
adolescent (624) 624
efficacy (623) 623
care and treatment (609) 609
rats (608) 608
antidepressive agents, second-generation - therapeutic use (607) 607
serotonin reuptake inhibitors (582) 582
serotonin uptake inhibitors - pharmacology (572) 572
drug therapy (570) 570
psychiatric status rating scales (552) 552
serotonin uptake inhibitors (528) 528
anxiety (515) 515
dose-response relationship, drug (513) 513
major depressive disorder (509) 509
placebo (505) 505
analysis (461) 461
paroxetine - administration & dosage (439) 439
drugs (438) 438
fluvoxamine (418) 418
citalopram (413) 413
time factors (399) 399
depression - drug therapy (397) 397
antidepressant (370) 370
psychology, clinical (364) 364
serotonin uptake inhibitors - administration & dosage (364) 364
antidepressive agents - adverse effects (355) 355
venlafaxine (341) 341
antidepressive agents, second-generation - adverse effects (340) 340
serotonin - metabolism (322) 322
fluoxetine - therapeutic use (317) 317
medical research (317) 317
brain (312) 312
depressive disorder - psychology (309) 309
drug therapy, combination (308) 308
drug administration schedule (307) 307
imipramine (307) 307
medicine, general & internal (304) 304
reports (303) 303
health aspects (294) 294
clinical trials (293) 293
severity of illness index (291) 291
risk factors (286) 286
medicine, experimental (284) 284
young adult (277) 277
ssri (275) 275
comorbidity (272) 272
mental depression (270) 270
rats, sprague-dawley (268) 268
panic disorder (267) 267
obsessive-compulsive disorder (265) 265
venlafaxine hydrochloride (265) 265
drug interactions (262) 262
disorder (259) 259
psychology (257) 257
mice (253) 253
antidepressive agents - pharmacology (252) 252
placebo-controlled trial (251) 251
pharmacotherapy (246) 246
randomized controlled trials as topic (241) 241
brain - metabolism (240) 240
serotonin transporter (237) 237
universities and colleges (237) 237
citalopram - therapeutic use (235) 235
phenols (234) 234
medicine & public health (232) 232
prevalence (232) 232
dosage and administration (230) 230
symptoms (230) 230
sertraline - therapeutic use (222) 222
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6923) 6923
French (57) 57
German (55) 55
Japanese (30) 30
Spanish (27) 27
Russian (19) 19
Chinese (15) 15
Italian (12) 12
Dutch (11) 11
Turkish (9) 9
Czech (5) 5
Norwegian (5) 5
Polish (5) 5
Portuguese (5) 5
Korean (4) 4
Danish (3) 3
Hungarian (3) 3
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of the American Academy of Child and Adolescent Psychiatry, ISSN 0890-8567, 2009, Volume 48, Issue 3, pp. 330 - 339
Objective: To advance knowledge regarding strategies for treating selective serotonin reuptake inhibitor (SSRI)-resistant depression in adolescents, we... 
Treatment-resistant | Depression | Cognitive-behavioral therapy | Adolescents | adolescents | PSYCHIATRY | PSYCHOLOGY, DEVELOPMENTAL | PSYCHOTHERAPY | cognitive-behavioral therapy | RELIABILITY | RANDOMIZED CONTROLLED-TRIAL | MAJOR DEPRESSION | PHARMACOTHERAPY | CHILDREN | INTERVENTIONS | CLINICAL-TRIALS | PEDIATRICS | depression | COLLABORATIVE RESEARCH-PROGRAM | SCALE | treatment-resistant | Outcomes of Treatment | Behavior Modification | Cognitive Restructuring | Drug Therapy | Predictor Variables | Psychological Patterns | Counseling Effectiveness | Depression (Psychology) | Counseling Techniques | Symptoms (Individual Disorders) | Antidepressive Agents, Second-Generation - adverse effects | Cyclohexanols - adverse effects | Prognosis | Humans | Depressive Disorder - diagnosis | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Depressive Disorder - drug therapy | Male | Combined Modality Therapy | Paroxetine - therapeutic use | Cognitive Behavioral Therapy | Antidepressive Agents, Second-Generation - therapeutic use | Paroxetine - adverse effects | Venlafaxine Hydrochloride | Personality Inventory | Adolescent | Cyclohexanols - therapeutic use | Female | Depressive Disorder - psychology | Fluoxetine - therapeutic use | Chronic Disease | Drug Resistance | Fluoxetine - adverse effects | Cognitive therapy | Serotonin agents | Patient outcomes | Depression, Mental | Adolescent medicine | Dosage and administration | Drug therapy | Teenagers | Inhibitor drugs | Mental depression | Medical treatment | Clinical outcomes
Journal Article
Journal Article
American Journal of Psychiatry, ISSN 0002-953X, 04/2009, Volume 166, Issue 4, pp. 418 - 426
Objective: The authors sought to identify predictors of self-harm adverse events in treatment-resistant, depressed adolescents during the first 12 weeks of... 
TRIALS | METAANALYSIS | INVENTORY | PSYCHIATRY | ANTIDEPRESSANT TREATMENT | RISK | TADS | SCALE | IDEATION | CHILDREN | Cyclohexanols - adverse effects | Humans | Suicide, Attempted - statistics & numerical data | Citalopram - adverse effects | Male | Paroxetine - therapeutic use | Cognitive Behavioral Therapy | Paroxetine - adverse effects | Drug Interactions | Self-Injurious Behavior - epidemiology | Suicide - psychology | Female | Fluoxetine - therapeutic use | Drug Therapy, Combination | Drug Resistance | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Cross-Sectional Studies | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Suicide - statistics & numerical data | Antidepressive Agents - therapeutic use | Suicide, Attempted - psychology | Venlafaxine Hydrochloride | Self-Injurious Behavior - chemically induced | Adolescent | Cyclohexanols - therapeutic use | Citalopram - therapeutic use | Benzodiazepines - adverse effects | Antidepressive Agents - adverse effects | Benzodiazepines - therapeutic use | Cognitive therapy | Venlafaxine | Influence | Serotonin uptake inhibitors | Dosage and administration | Suicide | Drug therapy | Self-destructive behavior | Risk factors | Depression in adolescence | Methods | Depressive Disorders | Drug Abuse | SSRIs | Comorbidity | Survivors | Americans | Self Inflicted Wounds | Self Destructive Behavior | Benzodiazepines | Randomized Clinical Trial | Atypical Antidepressants | Suicidality | Predisposition | Interpersonal Interaction | Alcohol Abuse | Adolescents | Negative Therapeutic Reaction | Stressors | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
JAMA Psychiatry, ISSN 2168-622X, 04/2017, Volume 74, Issue 4, pp. 370 - 378
Journal Article